Mechanistically, we confirm that cells harboring the deletion favor the splicing and expression of non-apoptotic isoforms of BIM, impairing the apoptotic response to GC exposure, and thereby promoting ALL cell survival. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.